期刊
BLOOD REVIEWS
卷 21, 期 5, 页码 255-265出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2007.01.002
关键词
monoclonal gammopathy; smoldering multiple myeloma; prognosis; treatment
类别
资金
- NCI NIH HHS [CA 107476, CA 62242] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P01CA062242, R01CA107476] Funding Source: NIH RePORTER
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic disorders characterized by monoclonal plasma cell proliferation in the bone marrow in the absence of end-organ damage. Updated diagnostic criteria for these disorders, risk-stratification models to determine prognosis, and the current management of these two entities are discussed in this review. (c) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据